SHMT2 and breast cancer: In addition, though upregulating the expression of the antioxidant enzymes HMOX1, SHMT2 and SLC7A11, breast cancer cells exhibited resistance to paclitaxel through the EIF2AK3/EIF2AK4-pEIF2S1-ATF4 axis 40.